Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Capital Leases (2025)

Vivos Therapeutics' Capital Leases history spans 1 years, with the latest figure at $113000.0 for Q4 2025.

  • Quarterly results put Capital Leases at $113000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $113000.0 (changed N/A YoY), and the annual figure for FY2025 was $113000.0, changed.
  • Capital Leases for Q4 2025 was $113000.0 at Vivos Therapeutics, down from $125000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $141000.0 in Q2 2025 to a low of $113000.0 in Q4 2025.